ALLO PEER ANALYSIS

Allogene Therapeutics Inc — metric-by-metric comparison with peers and the industry median

ALLOAllogene Therapeutics Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

ALLOIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	ALLO	MSB	TLX	RTALB	Ind. Median
P/E	—	—	—	4.89	17.91
P/B	1.79	—	6.37	0.61●	3.51
EV/EBITDA	—	—	120.14	74.61●	14.82
P/S	—	31.61	3.24●	6.67	10.89

Financial Health
Metric	ALLO	MSB	TLX	RTALB	Ind. Median
Current Ratio	9.65●	—	1.43	1.21	5.90
Debt/Equity	29.1%	—	112.3%	1.2%●	10.9%
NetDebt/EBITDA	1.16	—	13.13	0.90●	1.15

Profitability
Metric	ALLO	MSB	TLX	RTALB	Ind. Median
Net Margin	—	-115.3%	-0.9%	136.3%●	-125.7%
ROE	-52.3%	-11.3%	-1.8%	15.1%●	-47.5%
ROA	-38.4%	-8.6%	-0.7%	13.1%●	-35.8%
EBITDA Margin	—	-76.6%	3.0%	9.0%●	-105.8%

Growth + Dividend
Metric	ALLO	MSB	TLX	RTALB	Ind. Median
Rev. Growth	—	410.4%●	56.3%	24.0%	5.1%
NI Growth	—	—	—	134.0%	12.1%
Div. Yield	—	0.0%●	—	0.0%●	0.2%
Payout	—	0.0%	—	0.0%	0.0%

Valuation
Metric	ALLO	XFOR	AURA	PRTA	ARVN	NVCT	Ind. Median
P/E	—	—	—	—	—	—	17.91
P/B	1.79	3.10	4.87	1.68	1.39●	32.22	3.51
EV/EBITDA	—	—	—	—	—	—	14.82
P/S	—	57.86	—	9.05	6.01●	—	10.89

Financial Health
Metric	ALLO	XFOR	AURA	PRTA	ARVN	NVCT	Ind. Median
Current Ratio	9.65	10.18	7.09	10.43●	5.44	2.27	5.90
Debt/Equity	29.1%	45.9%	15.8%	2.4%	2.2%●	—	10.9%
NetDebt/EBITDA	1.16	1.74	0.88●	4.31	2.80	—	1.15

Profitability
Metric	ALLO	XFOR	AURA	PRTA	ARVN	NVCT	Ind. Median
Net Margin	—	-1,106.3%	—	-260.9%	-247.5%●	—	-125.7%
ROE	-52.3%	-104.2%	-95.6%	-40.3%●	-42.3%	-154.4%	-47.5%
ROA	-38.4%	-49.8%	-76.7%	-35.8%	-26.8%●	-97.8%	-35.8%
EBITDA Margin	—	-996.8%	—	-129.0%●	-242.2%	—	-105.8%

Growth + Dividend
Metric	ALLO	XFOR	AURA	PRTA	ARVN	NVCT	Ind. Median
Rev. Growth	—	-71.3%	-100.0%	-58.0%●	-79.1%	-100.0%	5.1%
NI Growth	—	—	—	—	—	—	12.1%
Div. Yield	—	—	—	—	—	—	0.2%
Payout	—	—	—	—	—	—	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on ALLO

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.